Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash from Investing Activities: 2018-2019

Historic Cash from Investing Activities for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $1.0 million.

  • DiaMedica Therapeutics' Cash from Investing Activities rose 7653.85% to $1.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$3.9 million, marking a year-over-year decrease of 7716.00%. This contributed to the annual value of $8.6 million for FY2024, which is 146.80% up from last year.
  • As of Q4 2019, DiaMedica Therapeutics' Cash from Investing Activities stood at $1.0 million, which was down 66.40% from $3.0 million recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Cash from Investing Activities registered a high of $3.0 million during Q2 2019, and its lowest value of -$10.9 million during Q1 2019.
  • Moreover, its 2-year median value for Cash from Investing Activities was $1,500 (2018), whereas its average is -$494,750.
  • Examining YoY changes over the last 5 years, DiaMedica Therapeutics' Cash from Investing Activities showed a top increase of 30,220.00% in 2019 and a maximum decrease of 34,050.00% in 2019.
  • Quarterly analysis of 2 years shows DiaMedica Therapeutics' Cash from Investing Activities stood at $13,000 in 2018, then soared by 7,653.85% to $1.0 million in 2019.
  • Its last three reported values are $1.0 million in Q4 2019, $3.0 million for Q3 2019, and $3.0 million during Q2 2019.